# Randomized Controlled Trial of LUtein as a Novel Neuroprotective Adjunctive Therapy to Improve Visual Outcome of Rhegmatogenous Retinal Detachment (LUNAR Study)

> **NCT03932305** · NA · COMPLETED · sponsor: **Singapore National Eye Centre** · enrollment: 110 (actual)

## Conditions studied

- Retinal Detachment

## Interventions

- **DIETARY_SUPPLEMENT:** Lutein
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03932305
- **Lead sponsor:** Singapore National Eye Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-25
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932305, "Randomized Controlled Trial of LUtein as a Novel Neuroprotective Adjunctive Therapy to Improve Visual Outcome of Rhegmatogenous Retinal Detachment (LUNAR Study)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03932305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
